Category Archives: Parkinson’s Treatment

A COVID-19 vaccination should be recommended to people with Parkinsons disease with caution reserved for very frail residents of long-term care settings, according to a new commentary published in the Journal of Parkinsons Disease. Patients and their physicians have expressed concern about vaccine efficacy and safety in people with Parkinsons, especially in the context of Parkinsons treatment. Following a research review and considering data from vaccinations to date, an international panel of neurologists has concluded that the overall risks of contracting COVID-19 for people with Parkinsons far outweigh the potential risks of vaccination, at least in cases of advanced disease, wrote lead author Stella M. Continue reading →

EU-backed health innovators, EIT Health today announced their support for two innovator teams following their 2020 Wild Card programme, selecting Spain-based MiMARK and German-based Orbit Health. Continue reading →

NEW YORK, Feb. 3, 2021 /PRNewswire/ --With the onset of a world health crisis, our seniors are at a greater risk than they were a decade ago Continue reading →

The "Alzheimer's Disease Treatment Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. Continue reading →

February is kicking off with a number of PDUFA dates for the U.S. Continue reading →

American Heart Month February is American Heart Month. Cardiovascular disease is the leading cause of death in The United States and approximately 1.5 million heart attacks and strokes occur every year. Morethan 800,000 people in the U.S Continue reading →

AstraZenecas COVID-19 vaccine reduced transmission of the virus and appeared to offer protection with one dose, a new study found. The results may support the U.K.s plan to delay second shots. (AP) Jazz Pharmaceuticals announced it will buy GW Pharma for $7.2 billion Continue reading →

The coronavirus pandemic dominated the headlines and our daily lives for most of the past year. Medical News Today have covered this fast-moving, complex story with live updates on the latest news, interviews with experts, and an ongoing investigation into the deep racial disparities that COVID-19 has helped unmask. However, this hasnt stopped us from publishing hundreds of fascinating stories on a myriad of other topics Continue reading →

NEW YORK, Feb. 1, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in Canaccord Genuity's New Paradigms and Treatment Approaches in Mental Health virtual conference, Wednesday, February 3rd and Thursday, February 4th, 2021. Continue reading →

- First potentially disease-modifying gene therapy for GM2 gangliosidosis to enter clinical studies - Expect to continue patient identification, screening, and enrollment in Stage 1 of the study throughout 2021 NEW YORK and RESEARCH TRIANGLE PARK, N.C., Feb. Continue reading →